Label: METOPROLOL TARTRATE- metoprolol tartrate tablet, film coated
METOPROLOL TARTRATE tablet, film coated

  • NDC Code(s): 71335-0689-1, 71335-0689-2, 71335-0689-3, 71335-0689-4, view more
  • Packager: Bryant Ranch Prepack
  • This is a repackaged label.
  • Source NDC Code(s): 42543-001, 42543-002, 42543-003
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 11, 2019

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    Metoprolol tartrate is a selective beta1-adrenoreceptor blocking agent, available as 25 mg, 50 mg, and 100 mg tablets for oral administration. Metoprolol tartrate is ...
  • CLINICAL PHARMACOLOGY
    Mechanism of Action - Metoprolol is a beta1-selective (cardioselective) adrenergic receptor blocker. This preferential effect is not absolute, however, and at higher plasma concentrations ...
  • Special Populations
    Geriatric Patients - The geriatric population may show slightly higher plasma concentrations of metoprolol as a combined result of a decreased metabolism of the drug in elderly population and a ...
  • Clinical Studies
    Hypertension - In controlled clinical studies, metoprolol has been shown to be an effective antihypertensive agent when used alone or as concomitant therapy with thiazide-type diuretics, at ...
  • INDICATIONS AND USAGE
    Hypertension - Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina ...
  • CONTRAINDICATIONS
    Hypertension and Angina - Metoprolol tartrate tablets are contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see ...
  • WARNINGS
    Heart Failure - Beta-blockers, like metoprolol, can cause depression of myocardial contractility and may precipitate heart failure and cardiogenic shock. If signs or symptoms of heart failure ...
  • Drug Interactions
    Catecholamine-Depleting Drugs - Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents or monoamine oxidase (MAO) inhibitors. Observe ...
  • ADVERSE REACTIONS
    Hypertension and Angina - Most adverse effects have been mild and transient. Central Nervous System - Tiredness and dizziness have occurred in about 10 of 100 patients. Depression has been ...
  • OVERDOSAGE
    Acute Toxicity - Several cases of overdosage have been reported, some leading to death. Oral LD - 50's (mg/kg): mice, 1,158 to 2,460; rats, 3,090 to 4,670 ...
  • DOSAGE AND ADMINISTRATION
    Hypertension - Individualize the dosage of metoprolol tartrate tablets. Metoprolol tartrate tablets should be taken with or immediately following meals. The usual initial dosage of metoprolol ...
  • HOW SUPPLIED
    Product: 71335-0689 - NDC: 71335-0689-1 30 TABLET, FILM COATED in a BOTTLE - NDC: 71335-0689-2 100 TABLET, FILM COATED in a BOTTLE - NDC: 71335-0689-3 60 TABLET, FILM COATED in a ...
  • Metoprolol Tartrate 100mg Tablet
    Label Image
  • Metoprolol tartrate 50mg Tablet
    Label Image
  • Metoprolol tartrate 25mg Tablet
    Label Image
  • INGREDIENTS AND APPEARANCE
    Product Information